-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$12.001664.71% Upside
BioXcel Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover BioXcel Therapeutics, Inc.?
BioXcel Therapeutics, Inc. has been rated by research analysts at Mizuho Securities, H.C. Wainwright, Guggenheim in the past 90 days.